Correlation Between Ford and Aclaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ford and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ford and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ford Motor and Aclaris Therapeutics, you can compare the effects of market volatilities on Ford and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ford with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ford and Aclaris Therapeutics.
Diversification Opportunities for Ford and Aclaris Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ford and Aclaris is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Ford Motor and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Ford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ford Motor are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Ford i.e., Ford and Aclaris Therapeutics go up and down completely randomly.
Pair Corralation between Ford and Aclaris Therapeutics
Taking into account the 90-day investment horizon Ford is expected to generate 38.88 times less return on investment than Aclaris Therapeutics. But when comparing it to its historical volatility, Ford Motor is 5.23 times less risky than Aclaris Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Aclaris Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 115.00 in Aclaris Therapeutics on September 2, 2024 and sell it today you would earn a total of 292.00 from holding Aclaris Therapeutics or generate 253.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ford Motor vs. Aclaris Therapeutics
Performance |
Timeline |
Ford Motor |
Aclaris Therapeutics |
Ford and Aclaris Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ford and Aclaris Therapeutics
The main advantage of trading using opposite Ford and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ford position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.The idea behind Ford Motor and Aclaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Aclaris Therapeutics vs. Crinetics Pharmaceuticals | Aclaris Therapeutics vs. Enanta Pharmaceuticals | Aclaris Therapeutics vs. Amicus Therapeutics | Aclaris Therapeutics vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |